Tags

,

The first combination of drugs to bolster the immune system to fight cancer has been approved, giving Bristol-Myers Squibb an early lead over competitors.


from NYT > Business Day http://ift.tt/1WAEWN1
via IFTTThttp://ift.tt/1WAEWMV http://ift.tt/IP98QF

Advertisements